152 related articles for article (PubMed ID: 8934649)
1. ISCOMs (immunostimulating complexes): the first decade.
Barr IG; Mitchell GF
Immunol Cell Biol; 1996 Feb; 74(1):8-25. PubMed ID: 8934649
[TBL] [Abstract][Full Text] [Related]
2. ISCOMs: an adjuvant with multiple functions.
Sjölander A; Cox JC; Barr IG
J Leukoc Biol; 1998 Dec; 64(6):713-23. PubMed ID: 9850152
[TBL] [Abstract][Full Text] [Related]
3. ISCOM-based vaccines: the second decade.
Sanders MT; Brown LE; Deliyannis G; Pearse MJ
Immunol Cell Biol; 2005 Apr; 83(2):119-28. PubMed ID: 15748208
[TBL] [Abstract][Full Text] [Related]
4. From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.
Lycke N
Cell Microbiol; 2004 Jan; 6(1):23-32. PubMed ID: 14678328
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulating complexes incorporating Eimeria tenella antigens and plant saponins as effective delivery system for coccidia vaccine immunization.
Berezin VE; Bogoyavlenskiy AP; Tolmacheva VP; Makhmudova NR; Khudyakova SS; Levandovskaya SV; Omirtaeva ES; Zaitceva IA; Tustikbaeva GB; Ermakova OS; Aleksyuk PG; Barfield RC; Danforth HD; Fetterer RH
J Parasitol; 2008 Apr; 94(2):381-5. PubMed ID: 18564738
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703.
Hu KF; Regner M; Siegrist CA; Lambert P; Chen M; Bengtsson KL; Morein B
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):269-76. PubMed ID: 15681158
[TBL] [Abstract][Full Text] [Related]
7. ISCOMs and ISCOMATRIX.
Sun HX; Xie Y; Ye YP
Vaccine; 2009 Jul; 27(33):4388-401. PubMed ID: 19450632
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems.
Sanina N; Chopenko N; Mazeika A; Kostetsky E
Biomed Res Int; 2017; 2017():4389525. PubMed ID: 28808657
[TBL] [Abstract][Full Text] [Related]
9. On the preparation, microscopic investigation and application of ISCOMs.
Myschik J; Lendemans DG; McBurney WT; Demana PH; Hook S; Rades T
Micron; 2006; 37(8):724-34. PubMed ID: 16750912
[TBL] [Abstract][Full Text] [Related]
10. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
[TBL] [Abstract][Full Text] [Related]
11. Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production.
Fernando GJ; Stenzel DJ; Tindle RW; Merza MS; Morein B; Frazer IH
Vaccine; 1995; 13(15):1460-7. PubMed ID: 8578827
[TBL] [Abstract][Full Text] [Related]
12. [Enhancing the immunogenic activity of influvac vaccine in the use of adjuvant TI complexes modified by echinochrome A].
Tsybul'skiĭ AV; Popov AM; Artiukov AA; Mazeĭka AN; Kostetskiĭ É; Sanina NM; Krivoshapko ON
Vopr Virusol; 2012; 57(2):23-7. PubMed ID: 22834143
[TBL] [Abstract][Full Text] [Related]
13. An Updated Review of ISCOMSTM and ISCOMATRIXTM Vaccines.
Garcia A; Lema D
Curr Pharm Des; 2016; 22(41):6294-6299. PubMed ID: 27634183
[TBL] [Abstract][Full Text] [Related]
14. The iscom: an immunostimulating system.
Morein B
Immunol Lett; 1990 Aug; 25(1-3):281-3. PubMed ID: 2283159
[TBL] [Abstract][Full Text] [Related]
15. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
[TBL] [Abstract][Full Text] [Related]
16. Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens.
Glück R
Vaccine; 1992; 10(13):915-9. PubMed ID: 1471412
[TBL] [Abstract][Full Text] [Related]
17. On the dilution behaviour of immuno-stimulating complexes (ISCOMs).
Lendemans DG; Egert AM; Myschik J; Hook S; Rades T
Pharmazie; 2006 Aug; 61(8):689-95. PubMed ID: 16964712
[TBL] [Abstract][Full Text] [Related]
18. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
19. Current status and potential application of ISCOMs in veterinary medicine.
Morein B; Hu KF; Abusugra I
Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
[TBL] [Abstract][Full Text] [Related]
20. Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants.
Rivera-Patron M; Cibulski SP; Miraballes I; Silveira F
Methods Mol Biol; 2022; 2469():183-191. PubMed ID: 35508839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
